Literature DB >> 8427529

Non-Hodgkin's lymphoma: initial manifestation.

M R Roldan, F Martinez, J Roman, A Torres.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8427529      PMCID: PMC1004970          DOI: 10.1136/ard.52.1.85

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Non-Hodgkin's lymphoma presenting as knee monoarthritis with a popliteal cyst.

Authors:  K K Haase; H Dürk; A Baumbach; J Saal; M Wehrmann
Journal:  J Rheumatol       Date:  1990-09       Impact factor: 4.666

2.  Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome.

Authors:  D J McCarty; J D O'Duffy; L Pearson; J B Hunter
Journal:  JAMA       Date:  1985-11-15       Impact factor: 56.272

3.  Lymphoma presenting in bone: results of histopathology, staging, and therapy.

Authors:  R R Reimer; B A Chabner; R C Young; R Reddick; R E Johnson
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

4.  Non-Hodgkin's lymphoma of the synovium simulating rheumatoid arthritis.

Authors:  H D Dorfman; H L Siegel; M C Perry; R Oxenhandler
Journal:  Arthritis Rheum       Date:  1987-02

5.  Primary lymphoma of bone presenting as monoarthritis.

Authors:  D M Rice; E Semble; E T Ahl; S P Bohrer; H Rothberger
Journal:  J Rheumatol       Date:  1984-12       Impact factor: 4.666

  5 in total
  3 in total

1.  Remitting seronegative symmetrical synovitis with pitting edema syndrome associated with non-Hodgkin's lymphoma: a case report.

Authors:  Mehmet Sayarlioglu; Irfan Bayram; Hayriye Sayarlioglu; Reha Erkoc
Journal:  Clin Rheumatol       Date:  2004-02-24       Impact factor: 2.980

Review 2.  Paraneoplastic syndromes in rheumatology.

Authors:  Bernhard Manger; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 3.  Paraneoplastic rheumatic syndromes.

Authors:  H J Mitnick
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.